Glioblastoma, one of the most aggressive and lethal brain cancers, may finally be showing a few cracks in its armor...

The quest for effective medications and therapies isn't only about what works, it's about demonstrating value...

An integral yet sometimes overlooked component of a successful drug launch is the development of a comprehensive medical communications plan

As the end of 2024 quickly approaches, we wanted to take a moment to reflect on all that has happened over the course of this year...

With growing scrutiny of the role PBMs play in the pharmaceutical supply chain, we dive into the FTC’s recent administrative complaint...

Learn what this year's internship cohort had to say about their internship experience in the Healthcare Communications and Innovation space

Organizations are moving to the approval readiness meeting, a model that lets them make field teams productive on Day One...

In healthcare, AI is poised to transform the delivery of services – promising improved efficiency, accuracy, and accessibility...

Setting clinical trial teams up for success means giving them the resources they need to effectively collaborate and engage ...

Based on our own qualitative primary research conducted with payers, we have an idea on what is keeping them up at night.

As 2023 comes to a close and 2024 sits on the horizon we wanted to take a moment to look ahead to all that may be in store.

There is a lot to accomplish during the post-launch period to ensure a product's success. Here are 6 key priorities to keep top of mind.

It’s not news that the United States has an obesity problem. However, newer medications are the first truly effective obesity treatments...

A company's publication plan is one of the most important elements of a medical communication strategy ...

The FDA released new draft guidelines for their accelerated approval process, learn what they are and why they're being created ...

The IRA reforms on prescription drug pricing and coverage is definitely on payers' radar. See what else our research uncovered ...

It is important to address these 7 areas as part of your pre-launch strategy to help ensure a successful drug launch.

Enlisting input and guidance from KOLs is critical to the development of brands. Learn about 5 key drivers for successful engagement ...

While Digital Therapeutics offer great promise and renewed hope to improve patient outcomes, they need to overcome several challenges...

Understanding the nuances of KOL Mapping can help increase a mapping project’s success. Be sure to consider these 5 important aspects...